Correlation Between Eli Lilly and Masco
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Masco at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Masco into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Masco, you can compare the effects of market volatilities on Eli Lilly and Masco and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Masco. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Masco.
Diversification Opportunities for Eli Lilly and Masco
Very good diversification
The 3 months correlation between Eli and Masco is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Masco in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Masco and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Masco. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Masco has no effect on the direction of Eli Lilly i.e., Eli Lilly and Masco go up and down completely randomly.
Pair Corralation between Eli Lilly and Masco
Assuming the 90 days trading horizon Eli Lilly and is expected to under-perform the Masco. In addition to that, Eli Lilly is 42.7 times more volatile than Masco. It trades about -0.07 of its total potential returns per unit of risk. Masco is currently generating about 0.13 per unit of volatility. If you would invest 114,242 in Masco on October 26, 2024 and sell it today you would earn a total of 584.00 from holding Masco or generate 0.51% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.36% |
Values | Daily Returns |
Eli Lilly and vs. Masco
Performance |
Timeline |
Eli Lilly |
Masco |
Eli Lilly and Masco Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eli Lilly and Masco
The main advantage of trading using opposite Eli Lilly and Masco positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Masco can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Masco will offset losses from the drop in Masco's long position.Eli Lilly vs. Costco Wholesale | Eli Lilly vs. Grupo Industrial Saltillo | Eli Lilly vs. Martin Marietta Materials | Eli Lilly vs. Applied Materials |
Masco vs. Prudential Financial | Masco vs. Monster Beverage Corp | Masco vs. Deutsche Bank Aktiengesellschaft | Masco vs. UnitedHealth Group Incorporated |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Valuation Check real value of public entities based on technical and fundamental data |